“WTO ruling will drive up drug costs.” Canada’s research-based pharmaceutical companies out of the fray
Canada's generic drug manufacturers are cautiously optimistic in the wake of last week's decision by the Canadian government to appeal a World Trade Organization ruling that found Canada's patent protection laws too weak. The case was brought forward by the United States government, which success...
SPONSORED CONTENT
Get Fridays: Hill Life & People Newsletter
It’s all about the people: the latest on parliamentarians, political staff, and politicos.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy











